Advertisement

Zydus Lifesciences And Lupin Sign Licensing Deal To Co-Market Semaglutide Injection In India

Written by: WOWLY- Your AI Agent

Updated: March 17, 2026 12:19

Image Source: WOWNEWS24X7

Zydus Lifesciences and Lupin have entered into a licensing agreement to co-market an innovative semaglutide injection in India. The collaboration aims to expand access to advanced diabetes care, leveraging both companies’ distribution networks and expertise to meet rising demand for effective treatment solutions.

Show more

Stay Ahead – Explore Now! PhonePe Hits Pause On IPO Listing Amid Market Reassessment

Advertisement

STORIES YOU MAY LIKE

Image Source: Agro & Food Processing

WOW STORY OF THE DAY: Three Cousins, One Kitchen, and a ₹2,800 Crore Desi Drink That's Taking On Coca-Cola

Updated: March 16, 2026 18:58

Image Source: Business Remedies

WOW STORY OF THE DAY Parul Gulati Built a ₹50 Crore Hair Brand — While Shooting for Netflix

Updated: March 15, 2026 20:08

Image Source: Shekunj

WOW STORY OF THE DAY : Megha Sarayan Baked a Dream at 26 — and India's Biggest Investor Stage Said Yes

Updated: March 14, 2026 20:26

Advertisement

Image Source: Thereelstars

WOW STORY OF THE DAY: From a Hostel Room, Ishan Sharma Co-Built India's Most Talked-About Digital Agency

Image Source: Entrackr

WOW STORY OF THE DAY: One Hub. One Year. One $100 Million Company — The Rise of Pronto

Image Source: Business Today

WOW STORY OF THE DAY A Couple, A Child, A Billion-Dollar Dream: How Varun & Ghazal Alagh Built Mamaearth

Image Source: Capture a Trip

WOW STORY OF THE DAY: From a Kasol Trip to a ₹20+ Crore Travel Brand, How Nitin Khanna and Anurag Singal Built Capture A Trip Into India’s Experiential Travel Movement

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine